What research says about cancer risk
Several research articles points
out the The authors of an article in the
British Journal of Cancer suggested that the inflammatory process itself
provides the prerequisite for the development of malignancy ¹. Inflammation is a critical When the two inflammatory markers
IL-6 and C-reactive protein (CRP) was measured in a group with breast cancer, a
Insulin resistance has shown to
increase inflammation and it has been documented that elevated CRP levels are
associated with increased fasting insulin levels and fasting glu In the article “Insulin and Cancer,
Boyd describes the link between insulin and the etiology as well as the
prognosis of cancer in the The Remember you don’t have to have diabetes to be at increased risk. The good news is that you can reduce these risk factors by implementing certain dietary changes. The diet should be low glycemic index which means it should not cause a big rise in blood sugar.
However it should not only be low
glycemic index, it also needs to include specific You can learn more about this by logging on to our website www.TissueRecovery.com. There you will find both e-books and a program which we can print for you if you like.
Following this program has shown
significant changes in the biochemistry in only some few weeks.
Wishing you the best of health, Didrik References:
1.
O’Byrne KL,
Dalgleish AG. Chronic immune activation and inflammation as the cause of
malignancy. Br J Cancer 2001;85(4):473-83. 2.
Coussens LM, Werb
Z. Inflammation and cancer. Nature 2002;420(6917):860-7. 3.
Zakrzewska I,
Kozlowski L, Wojtukiewicz M. Assessment of changes in levels of interleukin 6
and C reactive protein in patients with breast tumors. Pol Merkuriusz Lek
2003;15(85):115-7. 4.
Erlinger TP, Platz
EA, Rifai N, Helzlsouer KJ. C-reactive protein and the risk of incident 5.
Nakanishi N,
Shiraishi T, Wada M. Association between C-reactive protein and insulin
resistance in a Japanese population: the Minoh Study. Intern Med
2005;44(6):542-7. 6.
Boyd DB. Insulin
and cancer. Integr Cancer Ther 2003;2(4):315-29. 7.
Jee SH, Ohrr H,
Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glu
|